Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17339618 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: placebo;   Drug: ALX1-11

Indicates status has not been verified in more than two years